Balyasny Asset Management’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $19.6K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $41.6K | Sell |
|
|||||
|
2022
Q3 | $3.25M | Buy |
|
|||||
|
2022
Q2 | $388K | Sell |
|
|||||
|
2022
Q1 | $2.52M | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $1.17M | Buy |
|
|||||
|
2021
Q2 | $512K | Sell |
|
|||||
|
2021
Q1 | $3.06M | Sell |
|
|||||
|
2020
Q4 | $5.61M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $4.22M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $389K | Buy |
|
|||||
|
2018
Q3 | $641K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $191K | Sell |
|
|||||
|
2015
Q3 | $180K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $3.48M | Buy |
|